Literature DB >> 28418285

A new predictive tool for postoperative radiotherapy in prostate cancer.

Daniel K Lee1, William D Figg1.   

Abstract

The standard treatments of localized prostate cancer include surgical resection and/or radiotherapy. Recently in 2016, Zhao et al. described a tool to predict which patients will most likely gain from postoperative radiotherapy. Such a method can personalize treatment plan by maximizing benefit but minimizing harm.

Entities:  

Keywords:  Predictive tool; prostate cancer; radiotherapy

Mesh：

Substances：

Year:  2017        PMID： 28418285      PMCID： PMC5499754          DOI： 10.1080/15384047.2017.1310347

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


  10 in total

1.  The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.

Authors:  Matthew R Cooperberg; Joan F Hilton; Peter R Carroll
Journal:  Cancer       Date:  2011-06-03       Impact factor: 6.860

2.  Modern Risk Assessment for Individualizing Treatment Concepts in Early-stage Breast Cancer.

Authors:  Alex Farr; Rachel Wuerstlein; Annika Heiduschka; Christian F Singer; Nadia Harbeck
Journal:  Rev Obstet Gynecol       Date:  2013

3.  Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.

Authors:  Shuang G Zhao; S Laura Chang; Daniel E Spratt; Nicholas Erho; Menggang Yu; Hussam Al-Deen Ashab; Mohammed Alshalalfa; Corey Speers; Scott A Tomlins; Elai Davicioni; Adam P Dicker; Peter R Carroll; Matthew R Cooperberg; Stephen J Freedland; R Jeffrey Karnes; Ashley E Ross; Edward M Schaeffer; Robert B Den; Paul L Nguyen; Felix Y Feng
Journal:  Lancet Oncol       Date:  2016-10-12       Impact factor: 41.316

4.  Addressing the needs of the high-risk prostate cancer patient.

Authors:  Leonard G Gomella
Journal:  Rev Urol       Date:  2005

Review 5.  Prostate cancer diagnostics: Clinical challenges and the ongoing need for disruptive and effective diagnostic tools.

Authors:  Shikha Sharma; Julia Zapatero-Rodríguez; Richard O'Kennedy
Journal:  Biotechnol Adv       Date:  2016-12-06       Impact factor: 14.227

Review 6.  Radiotherapy in the management of prostate cancer after radical prostatectomy.

Authors:  Detlef Bartkowiak; Dirk Bottke; Thomas Wiegel
Journal:  Future Oncol       Date:  2013-05       Impact factor: 3.404

7.  Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

Authors:  J Cuzick; D M Berney; G Fisher; D Mesher; H Møller; J E Reid; M Perry; J Park; A Younus; A Gutin; C S Foster; P Scardino; J S Lanchbury; S Stone
Journal:  Br J Cancer       Date:  2012-02-23       Impact factor: 7.640

8.  Management of biochemical recurrence after primary localized therapy for prostate cancer.

Authors:  Oussama M Darwish; Ganesh V Raj
Journal:  Front Oncol       Date:  2012-05-23       Impact factor: 6.244

9.  A 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical Prostatectomy.

Authors:  Michael Marrone; Arnold L Potosky; David Penson; Andrew N Freedman
Journal:  PLoS Curr       Date:  2015-11-17

10.  Salvage radiotherapy after radical prostatectomy: prediction of biochemical outcomes.

Authors:  Ohseong Kwon; Ki Bom Kim; Young Ik Lee; Seok-Soo Byun; Jae-Sung Kim; Sang Eun Lee; Sung Kyu Hong
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.